ABOUT CELYAD ONCOLOGY
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer
Latest News
Our SCIENCE
At Celyad Oncology, we are pursuing next-generation cellular immunotherapies by applying our broad understanding of immunology, novel technology platforms and modular design approach to drug discovery.
Novel CAR T Immunotherapies
Advancing both allogeneic and autologous CAR T therapy candidates for the treatment of cancer
Stay informed about the latest news!
Sign up FOR our newsletter
Please enter a valid email address.
Thanks for subscribing! Please check your email for further instructions.
Something went wrong. Please check your entries and try again.
By clicking on “send”, you accept that your data will be sent to us and processed by our provider in order to send you our newsletter. You can find more information on how we process your data in our Privacy Policy.
